Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

Auckland City Hospital ( Site 0011), Auckland

Chris OBrien Lifehouse ( Site 0006), Sydney

Westmead Hospital ( Site 0009), Sydney

Blacktown Hospital Western Sydney Local Health District ( Site 0008), Blacktown

Port Macquarie Base Hospital ( Site 0001), Port Macquarie

Tauranga Hospital ( Site 0004), Tauranga

Ballarat Health Services ( Site 0003), Ballarat

The Prince Charles Hospital ( Site 0010), Chermside

Cairns Hospital ( Site 0002), Cairns

National Cancer Center ( Site 0061), Goyang-si

Hopital Nord du Marseille ( Site 0147), Marseille

Broome Oncology, LLC ( Site 0562), Johnson City

Complejo Hospitalario Universitario A Coruna ( Site 0239), A Coruña

The Catholic University of Korea St. Vincent s Hospital ( Site 0064), Gyeonggi-do

Abington Hospital - Asplundh Cancer Center ( Site 0575), Willow Grove

Thomas Jefferson University Hospital ( Site 0548), Philadelphia

Hamato-Onkologie Hamburg Prof. Laack und Partner ( Site 0161), Hamburg

LungenClinic Grosshansdorf GmbH ( Site 0171), Großhansdorf

Pius Hospital Oldenburg ( Site 0170), Oldenburg

West Virginia University ( Site 0526), Morgantown

Hospital General Universitario Gregorio Maranon ( Site 0237), Madrid

Hospital Clinico San Carlos ( Site 0235), Madrid

Hospital Universitario La Paz ( Site 0236), Madrid

Chungbuk National University Hospital ( Site 0062), Cheongju-si

Complejo Hospitalario de Malaga ( Site 0238), Málaga

Holy Cross Hospital ( Site 0512), Fort Lauderdale

Centre de Cancerologie du Grand Montpellier ( Site 0142), Montpellier

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0312), Istanbul

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0310), Istanbul

Hospital Universitario Insular de Gran Canaria ( Site 0244), Las Palmas de Gran Canaria

Ege Universitesi Tip Fakultesi ( Site 0313), Izmir

West Cancer Center - East Campus ( Site 0544), Germantown

Mercy Health-Paducah Medical Oncology and Hematology ( Site 0570), Paducah

Hopital Laennec ( Site 0146), Nantes

Inonu Universitesi Medical Fakultesi ( Site 0318), Malatya

Hospital General Universitario de Valencia ( Site 0231), Valencia

Hospital Universitario La Fe ( Site 0233), Valencia

Henry Ford Health System ( Site 0563), Detroit

Hospital Universitario Miguel Servet ( Site 0242), Zaragoza

Uniklinik RWTH Aachen ( Site 0160), Aachen

Hopital Robert Schuman ( Site 0143), Vantoux

Sanford Health Roger Maris Cancer Center ( Site 0533), Fargo

Krankenhaus Nordwest ( Site 0169), Frankfurt am Main

Saint Lukes Cancer Institute ( Site 0541), Kansas City

Universitaetsklinikum des Saarlandes ( Site 0165), Homburg

Centre Paul Strauss ( Site 0144), Strasbourg

Hopital Cardiologique Louis Pradel ( Site 0141), Bron

L'hopital Nord-Ouest - Centre Hospitalier de Villefranche sur Saone ( Site 0149), Villefranche-sur-Saône

Shamir Medical Center-Assaf Harofeh ( Site 0227), Ẕerifin

Stephenson Cancer Center ( Site 0504), Oklahoma City

Klinikum Esslingen GmbH ( Site 0164), Esslingen am Neckar

Hopital Cochin ( Site 0140), Paris

Parkland Health & Hospital System ( Site 0576), Dallas

UT Southwestern Medical Center ( Site 0558), Dallas

Utah Cancer Specialists ( Site 0523), Salt Lake City

Hopital Foch ( Site 0145), Suresnes

El Camino Hospital Cancer Center ( Site 0529), Mountain View

Good Samaritan Hospital Corvallis ( Site 0521), Corvallis

Peking Union Medical College Hospital ( Site 0108), Beijing

Cancer Hospital Chinese Academy of Medical Science ( Site 0117), Beijing

Beijing Cancer Hospital ( Site 0120), Beijing

City Clinical Hospital 1 na. NI. Pirogov ( Site 0270), Moscow

Central Clinical Hospital with outpatient Clinic ( Site 0262), Moscow

National Medical Research Radiology Centre ( Site 0260), Moscow

FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 0264), Moscow

Jilin Cancer Hospital ( Site 0115), Changchun

Moscow Regional Oncological Dispensary ( Site 0274), Balashikha

The Third Affiliated Hospital of Harbin Medical University ( Site 0100), Harbin

First Pavlov State Medical University of Saint Petersburg-Department of Oncology ( Site 0273), Saint Petersburg

Leningrad Regional Oncology Center ( Site 0271), Saint Petersburg

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0269), Saint Petersburg

Zhongshan Hospital Fudan University ( Site 0103), Shanghai

Shanghai Pulmonary Hospital ( Site 0101), Shanghai

Tianjin Medical University Cancer Institute & Hospital ( Site 0111), Tianjin

The First Affiliated Hospital Zhejiang University ( Site 0109), Hangzhou

Zhejiang Cancer Hospital ( Site 0113), Hangzhou

The First Affiliated Hospital of Wenzhou Medical University ( Site 0124), Wenzhou

Fujian Provincial Cancer Hospital ( Site 0102), Fuzhou

The Second Hospital Affiliated to AMU ( Site 0119), Chongqing

First Affiliated Hospital of The Third Military Medical University ( Site 0118), Chongqing

SAHI Republican Clinical Oncological Dispensary of the MoH of RT ( Site 0261), Kazan'

Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0123), Wuhan

Hubei Cancer Hospital ( Site 0122), Wuhan

Henan Cancer Hospital ( Site 0112), Zhengzhou

Southern Medical University Nanfang Hospital ( Site 0121), Guangzhou

Nizhniy Novgorod Region Oncology Dispensary ( Site 0272), Nizhny Novgorod

Omsk Clinical Oncology Dispensary ( Site 0267), Omsk

Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0110), Urumuqi

Centro Oncologico Antofagasta ( Site 0386), Antofagasta

Holy Family Hospital ( Site 0228), Nazareth

Oncocentro ( Site 0384), Viña del Mar

Rambam Medical Center ( Site 0223), Haifa

Clinica Universidad Catolica del Maule ( Site 0385), Talca

Meir Medical Center ( Site 0221), Kfar Saba

Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 0380), Temuco

Rabin Medical Center ( Site 0224), Petah Tikva

Sheba Medical Center ( Site 0220), Ramat Gan

Sourasky Medical Center ( Site 0225), Tel Aviv

OrlandiOncologia ( Site 0381), Santiago

Fundacion Arturo Lopez Perez FALP ( Site 0383), Santiago

Pontificia Universidad Catolica de Chile ( Site 0382), Santiago

Soroka Medical Center ( Site 0222), Beersheba

Bradford Hill Centro de Investigaciones Clinicas ( Site 0387), Santiago

Shaare Zedek Medical Center-Oncology ( Site 0229), Jerusalem

Yale University ( Site 0519), New Haven

Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0367), Berazategui

Instituto de Investigaciones Clinicas Mar del Plata ( Site 0371), Mar del Plata

CEMIC ( Site 0370), Buenos Aires

Sanatorio Parque ( Site 0365), Rosario

Hospital Aleman ( Site 0368), Buenos Aires

Instituto Medico Especializado Alexander Fleming ( Site 0369), Buenos Aires

CEMAIC ( Site 0374), Córdoba

CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica ( Site 0372), San Juan

Moncton Hospital - Horizon Health Network ( Site 0410), Moncton

Juravinski Cancer Centre ( Site 0407), Hamilton

Kingston Health Sciences Centre ( Site 0414), Kingston

Lakeridge Health ( Site 0406), Oshawa

Sault Area Hospital ( Site 0413), Sault Ste. Marie

Hopital Cite de la Sante de Laval ( Site 0400), Laval

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0412), Montreal

CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 0403), Québec

CIUSSS de la Mauricie et du Centre du Quebec ( Site 0408), Trois-Rivières

Krankenhaus Martha Maria Halle-Doelau ( Site 0166), Halle

National Hospital Organization Nagoya Medical Center ( Site 0017), Nagoya

Fujita Health University Hospital ( Site 0016), Toyoake

National Cancer Center Hospital East ( Site 0024), Kashiwa

Kanazawa University Hospital ( Site 0018), Kanazawa

Osaka Habikino Medical Center ( Site 0020), Habikino

Kansai Medical University Hospital ( Site 0022), Hirakata

Niigata Cancer Center Hospital ( Site 0019), Niigata

National Cancer Center Hospital ( Site 0026), Tokyo

Tokyo Metropolitan Komagome Hospital ( Site 0015), Tokyo

The Cancer Institute Hospital of JFCR ( Site 0021), Tokyo

Wakayama Medical University Hospital ( Site 0025), Wakayama

Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 0615), Pleszew

MED-POLONIA Sp. z o.o. ( Site 0609), Poznan

Centrum Onkologii im.prof. F. Lukaszczyka w Bydgoszczy ( Site 0601), Bydgoszcz

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0603), Warsaw

Szpital Wojewodzki im. Mikolaja Kopernika ( Site 0602), Koszalin

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii ( Site 0613), Lodz

Severance Hospital Yonsei University Health System ( Site 0063), Seoul

ICO L Hospitalet ( Site 0234), L'Hospitalet de Llobregat

Hospital General Universitario de Alicante ( Site 0240), Alicante

Hospital Santa Creu i Sant Pau ( Site 0241), Barcelona

Cukurova Universitesi Tıp Fakultesi Balcalı Hastanesi ( Site 0314), Adana

Hacettepe Universitesi Tıp Fakultesi ( Site 0316), Ankara

Ankara Universitesi Tip Fakultesi. ( Site 0317), Ankara

Ankara Sehir Hastanesi ( Site 0323), Ankara

Cambridge University Hospitals NHS Trust ( Site 0293), Cambridge

North Middlesex University Hospital NHS Trust ( Site 0291), London

Guys and St Thomas NHS Foundation Trust ( Site 0280), London

St Georges University Hospitals NHS Foundation Trust. ( Site 0292), London

Aberdeen Royal Infirmary ( Site 0288), Aberdeen

Leeds Teaching Hospital NHS Trust. St. James University Hospital ( Site 0276), Leeds

Leicester Royal Infirmary ( Site 0284), Leicester

Christie NHS Foundation Trust ( Site 0275), Manchester

The Clatterbridge Cancer Centre NHS Foundation Trust ( Site 0286), Metropolitan Borough of Wirral

Nottingham City Hospital Campus ( Site 0287), Nottingham